IDARUBICIN for Marrow hyperplasia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where IDARUBICIN was used for Marrow hyperplasia.
Most Reported Side Effects for IDARUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 758 | 15.1% | 94 | 414 |
| Off label use | 400 | 7.9% | 109 | 96 |
| Neutropenia | 383 | 7.6% | 93 | 137 |
| Pyrexia | 313 | 6.2% | 58 | 160 |
| Thrombocytopenia | 293 | 5.8% | 52 | 93 |
| Drug ineffective | 291 | 5.8% | 120 | 117 |
| Sepsis | 289 | 5.7% | 123 | 150 |
| Pancytopenia | 286 | 5.7% | 73 | 93 |
| Pneumonia | 239 | 4.7% | 91 | 121 |
| Septic shock | 227 | 4.5% | 129 | 143 |
| Acute myeloid leukaemia | 216 | 4.3% | 111 | 70 |
| Death | 214 | 4.3% | 214 | 15 |
| Myelosuppression | 208 | 4.1% | 14 | 104 |
| Product use in unapproved indication | 177 | 3.5% | 53 | 28 |
| Mucosal inflammation | 161 | 3.2% | 18 | 53 |
Other Indications for IDARUBICIN
Acute myeloid leukaemia (2,427)
Acute promyelocytic leukaemia (481)
Acute lymphocytic leukaemia (390)
Product used for unknown indication (243)
Chemotherapy (158)
Myelodysplastic syndrome (103)
Acute leukaemia (85)
Non-hodgkin's lymphoma (68)
Acute monocytic leukaemia (46)
B-cell type acute leukaemia (45)